These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 9331296

  • 1. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, Borowitz MJ.
    Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
    [Abstract] [Full Text] [Related]

  • 2. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O, Ichikawa M, Okamoto T, Park C, Motoji T, Mizoguchi H, Shibuya A.
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [Abstract] [Full Text] [Related]

  • 3. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A, Villamor N, Hernández-Boluda JC, Ferrer A, Camós M, Campo E, López-Guillermo A.
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [Abstract] [Full Text] [Related]

  • 4. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D.
    Cancer; 2002 May 01; 94(9):2401-8. PubMed ID: 12015765
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity.
    Falcão RP, Garcia AB, Marques MG, Simões BP, Fonseca BA, Rodrigues ML, Foss NT.
    Leuk Res; 2002 Sep 01; 26(9):803-7. PubMed ID: 12127554
    [Abstract] [Full Text] [Related]

  • 7. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X, Wasserman PG, Bhargava A, Iqbal U, Ragnauth S, Fuchs A.
    Arch Pathol Lab Med; 2004 Aug 01; 128(8):e100-3. PubMed ID: 15270596
    [Abstract] [Full Text] [Related]

  • 8. Blastoid NK cell leukemia/lymphoma with cutaneous involvement.
    Ginarte M, Abalde MT, Peteiro C, Fraga M, Alonso N, Toribio J.
    Dermatology; 2000 Aug 01; 201(3):268-71. PubMed ID: 11096204
    [Abstract] [Full Text] [Related]

  • 9. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R, Nakamura S.
    Leuk Res; 1999 Jul 01; 23(7):615-24. PubMed ID: 10400182
    [Abstract] [Full Text] [Related]

  • 10. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
    Natkunam Y, Cherry AM, Cornbleet PJ.
    Arch Pathol Lab Med; 2001 Mar 01; 125(3):413-8. PubMed ID: 11231495
    [Abstract] [Full Text] [Related]

  • 11. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH.
    Blood; 1997 Jun 15; 89(12):4501-13. PubMed ID: 9192774
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blastic natural killer cell lymphoma/leukemia: a report of seven cases.
    Bayerl MG, Rakozy CK, Mohamed AN, Vo TD, Long M, Eilender D, Palutke M.
    Am J Clin Pathol; 2002 Jan 15; 117(1):41-50. PubMed ID: 11789729
    [Abstract] [Full Text] [Related]

  • 15. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S, Otsuka M, Takeshita T, Mizukami K, Suzuki S, Uozumi K, Tashiro Y, Arima N, Hanada S.
    Int J Hematol; 2009 Mar 15; 89(2):188-194. PubMed ID: 19109730
    [Abstract] [Full Text] [Related]

  • 16. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
    Matano S, Nakamura S, Nakamura S, Annen Y, Hattori N, Kobayashi K, Kyoda K, Sugimoto T.
    Acta Haematol; 1999 Mar 15; 101(4):206-8. PubMed ID: 10436303
    [Abstract] [Full Text] [Related]

  • 17. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eilender D, Palutke M.
    Am J Clin Pathol; 2001 Aug 15; 116(2):168-76. PubMed ID: 11488062
    [Abstract] [Full Text] [Related]

  • 18. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement.
    Aoyama Y, Yamane T, Hino M, Ohta K, Nakamae H, Yamamura R, Koh KR, Takubo T, Inoue T, Tatsumi Y, Tatsumi N.
    Ann Hematol; 2001 Dec 15; 80(12):752-4. PubMed ID: 11797118
    [Abstract] [Full Text] [Related]

  • 19. Pediatric acute blastic natural killer cell leukemia.
    DuBois SG, Etzell JE, Matthay KK, Robbins E, Banerjee A.
    Leuk Lymphoma; 2002 Apr 15; 43(4):901-6. PubMed ID: 12153184
    [Abstract] [Full Text] [Related]

  • 20. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
    Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Suefuji H, Suzumiya J, Harada M, Kikuchi M.
    Am J Surg Pathol; 2003 Oct 15; 27(10):1366-74. PubMed ID: 14508398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.